Literature DB >> 3557872

The response of retinal vasculature to angiotensin.

E J Rockwood, F Fantes, E B Davis, D R Anderson.   

Abstract

A retinal arterial constriction was produced in anesthetized cats with a continuous transvitreal infusion of angiotensin I or angiotensin II (Ile-5). Constriction of vessels near the infusion cannula tip occurred over a range of angiotensin II concentrations from 10(-9) to 10(-4) molar, and was reversibly blocked by a ten-fold excess of the competitive antagonist saralasin. Constriction did not occur in response to angiotensin I if angiotensin-converting enzyme was blocked with Captopril. Control infusions of saline did not elicit a contraction of the retinal arteries. Severe axonal and inner retinal damage and necrosis occurred when angiotensin II produced a prolonged vasospasm, but not after infusion with control solutions, or when-constriction caused by angiotensin was brief.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3557872

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  The renin-angiotensin system in the human eye.

Authors:  N J Van Haeringen
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

Review 2.  Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma.

Authors:  C H Buckley; P W Hadoke; C J O'Brien
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  Adrenergic responses in isolated bovine retinal resistance arteries.

Authors:  P J Nielsen; N C Nyborg
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

4.  Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

Authors:  H Funatsu; H Yamashita; Y Nakanishi; S Hori
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

5.  Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.

Authors:  S Mäkimattila; P Summanen; I Matinlauri; M Mäntysaari; A Schlenzka; M Aalto; K Irjala; H Yki-Järvinen
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

6.  Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

Authors:  J Wagner; A H Jan Danser; F H Derkx; T V de Jong; M Paul; J J Mullins; M A Schalekamp; D Ganten
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  Utility of angiotensin-converting enzyme activity in aqueous humor in the diagnosis of ocular sarcoidosis.

Authors:  Violeta Mihailovic-Vucinic; Ljubica Popevic; Spasoje Popevic; Mihailo Stjepanovic; Andjelka Aleksic; Anka Stanojevic-Paovic
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

8.  Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture.

Authors:  Duri Kim; Ushasree Pattamatta; Elizabeth Kelly; Paul R Healey; Nicole Carnt; Hans Zoellner; Andrew J R White
Journal:  Transl Vis Sci Technol       Date:  2018-04-09       Impact factor: 3.283

Review 9.  The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons.

Authors:  Tariq E Farrah; Baljean Dhillon; Pearse A Keane; David J Webb; Neeraj Dhaun
Journal:  Kidney Int       Date:  2020-02-27       Impact factor: 10.612

10.  Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy.

Authors:  Samuel A Mills; Andrew I Jobling; Michael A Dixon; Bang V Bui; Kirstan A Vessey; Joanna A Phipps; Ursula Greferath; Gene Venables; Vickie H Y Wong; Connie H Y Wong; Zheng He; Flora Hui; James C Young; Josh Tonc; Elena Ivanova; Botir T Sagdullaev; Erica L Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.